Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1200-1208

  Mousseau, D D ^a,c   Baker, G B ^b   Butterworth, R F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

ATPase; Cirrhosis; Dopamine; Serotonin (5 hydroxytryptamine); Tryptamine; Tryptophan

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOGENIC AMINE; DOPAMINE; HOMOVANILLIC ACID; LAZABEMIDE; MESSENGER RNA; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; SEROTONIN; TRYPTOPHAN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; LIGAND BINDING; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

GYMNOMYZA SAMOENSIS;

EID: 0031016881     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031200.x     Document Type: Article

References (61)

1. Adams R. D. and Foley J. M. (1953) The neurological disorder associated with liver disease, in Metabolic and Toxic Diseases of the Nervous System, Vol. 32 (Merritt H. H. and Hare C. C., eds), pp. 198-237. Williams and Wilkins, Baltimore.
2. Aghajanian G. K., Rosecrans J. A., and Sheard M. H. (1967) Serotonin release in the forebrain by stimulation of midbrain raphe. Science 156, 402-403.
3. Bach A. W. J., Lan N. C., Johnson D. L., Abell C. W., Bembenek M. E., Kwan S.-W., Seeburg P. H., and Shin J. C. (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 85, 4934-4938.
4. Baker G. B., Coutts R. T., and Martin I. L. (1981) Measurements of amines in the central nervous system using gas chromatography with electron-capture detection. Prog. Neurobiol. 17, 1-24.
5. Baker G. B., Coutts R. T., and Rao T. S. (1987) Neuropharmacological and neurochemical properties of N-(cyanoethyl)-β-phenylethylamine, a prodrug of β-phenylethylamine. Br. J. Pharmacol. 92, 243-256.
6. Baldessarini R. J. and Fischer J. E. (1973) Serotonin metabolism in rat brain after surgical diversion of the portal venous system. Nature 245, 25-27.
7. Bergeron M., Reader T. A., Pomier Layrargues G., and Butterworth R. F. (1989) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res. 14, 853-859.
8. Bergeron M., Swain M. S., Reader T. A., Grondin L., and Butterworth R. F. (1990) Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J. Neurochem. 55, 222-229.
9. Brunner H. G., Nelen M., Breakefield X. O., Ropers H. H., and van Oost B. (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580.
10. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Müller U., Aguet M., Babinet C., Shih J. C., and De Maeyer E. (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268, 1763-1766.
11. Cavallero S., Pani L., Guidotti A., and Costa E. (1993) ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action. Life Sci. 53, 1137-1147.
12. 3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B. Eur. J. Pharmacol. 162, 457-465.
13. 3H]Ro 41-1049 to the active site of human monoamine oxidase-A. Mol. Pharmacol. 37, 358-366.
14. Chan-Palay V., Hochli M., Savaskan E., and Hungerecker G. (1993) Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease. Dementia 4, 1-15.
15. Chirgwin J. M., Przybyla A. E., MacDonald R. J., and Rutter W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
16. Costa M. R. C., Edelstein S. B., Castiglione C. M., Chao H., and Breakefield X. O. (1980) Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts. Biochem. Genet. 18, 577-590.
17. Della Corte L. and Callingham B. A. (1977) The influence of age and adrenalectomy on rat heart monoamine oxidase. Biochem. Pharmacol. 26, 407-415.
18. Denney R. M., Fritz R. R., Patel N. T., and Abell C. W. (1982) Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody. Science 215, 1400-1403.
19. Denney R. M., Sharma A., Dave S. K., and Waguespack A. (1994) A new look at the promoter of the human monoamine oxidase A gene: mapping transcription initiation sites and capacity to drive luciferase expression. J. Neurochem. 63, 843-856.
20. Edelstein S. B. and Breakefield X. O. (1986) Monoamine oxidase A and B are differentially regulated by glucocorticoids and "aging" in human skin fibroblasts. Cell. Mol. Neurobiol. 6, 121-150.
21. Erecińska M., Pastuszko A., Wilson D. F., and Nelson D. (1987) Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J. Neurochem. 49, 1258-1265.
22. Faraj B. A., Davis D. C., Camp V. M., Mooney A. J., Holloway T., and Barika G. (1994) Platelet monoamine oxidase activity in alcoholics, alcoholics with drug dependence, and cocaine addicts. Alcoholism Clin. Exp. Res. 18, 1114-1120.
23. Feinberg A. P. and Vogelstein B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
24. Holm E., Jacob S., Kortsik C., Leweling H., and Fischer B. (1988) Failure of selective serotonin reuptake inhibition to worsen the mental state of patients with subclinical hepatic encephalopathy, in Advances in Ammonia Metabolism and Hepatic Encephalopathy (Soeters P. B., Wilson J. H. P., Meijer A. J., and Holm E., eds), pp. 474-486. Elsevier Scientific, Amsterdam.
25. Holsboer F., Grasser A., Friess E., and Wiedemann K. (1994) Steroid effects on central neurons and implications for psychiatric and neurological disorders. Ann. NY Acad. Sci. 746, 345-359.
26. Hotamisligil G. S., Girmen A. S., Fink J. S., Tivol E., Shalish C., Trofatter J., Baenziger J., Diamond S., Markham C., Sullivan J., Growdon J., and Breakefield X. O. (1994) Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov. Disord. 9, 305-310.
27. Itzhak Y., Roig-Cantisano A., Dombro R. S., and Norenberg M. D. (1995) Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res. 705, 345-348.
28. Kanazawa I. (1983) Grid microdissection of human brain areas, in IBRO Handbook Series, Methods in the Neurosciences: Brain Microdissection Techniques (Cuello A. C., ed), pp. 127-153. Wiley and Sons, Toronto.
29. Kawada Y., Hattori M., Dai X., and Nanko S. (1995) Possible association between monoamine oxidase A gene and bipolar affective disorder. Am. J. Med. Genet. 56, 335-336.
30. Knell A. J., Davidson A. R., Williams R., Kantamanemi B. D., and Curzon G. (1974) Dopamine and serotonin metabolism in hepatic encephalopathy. Br. Med. J. 1, 549-551.
31. Kochersperger L. M., Waguespack A., Patterson J. C., Hsieh C. C., Weyler W., Salach J. I., and Denney R. M. (1985) Immunological uniqueness of human monoamine oxidases A and B: new evidence from studies with monoclonal antibodies to human monoamine oxidase A. J. Neurosci. 11, 2874-2881.
32. Laursen H. and Diemer N. H. (1980) Morphometry of astrocyte and oligodendrocyte ultrastructure after portacaval anastomosis in the rat. Acta Neuropathol. (Berl.) 51, 65-70.
33. Lavoie J., Pomier Layrargues G., and Butterworth R. F. (1990) Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. Hepatology 11, 874-878.
34. Lenders J. W. M., Eisenhofer G., Abeling N. G. G. M., Berger W., Murphy D. L., Konings C. H., Bleeker Wagemakers L. M., Kopin I. J., Karoum F., van Gennip A. H., and Brunner H. G. (1996) Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J. Clin. Invest. 97, 1010-1019.
35. Levitt P., Pintar J. E., and Breakefield X. O. (1982) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl. Acad. Sci. USA 79, 6385-6389.
36. Lindenmayer J. P. (1995) New pharmacotherapeutic modalities for negative symptoms in psychosis. Acta Psychiatr. Scand. Suppl. 388, 15-19.
37. Lyles G. A. and Callingham B. A. (1982) In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues. Biochem. Pharmacol. 31, 1417-1424.
38. Martin I. L. and Baker G. B. (1977) A gas-liquid chromatographic method for the estimation of 2-phenylethylamine in rat brain tissue. Biochem. Pharmacol. 26, 1513-1516.
39. Mousseau D. D. and Butterworth R. F. (1994) Current theories on the pathogenesis of hepatic encephalopathy. Proc. Soc. Exp. Biol. Med. 206, 329-344.
40. 2 receptor density in hepatic encephalopathy. Neurosci. Lett. 162, 192-196.
41. 3H] tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J. Neurochem. 62, 621-625.
42. +-ATPase activity is selectively increased in thalamus in thiamine deficiency prior to the appearance of neurological symptoms. Eur. J. Pharmacol. 300, 191-196.
43. Norenberg M. D. and Lapham L. W. (1974) The astrocyte response in experimental portal-systemic encephalopathy. An electron microscopic study. J. Neuropathol. Exp. Neurol. 33, 422-435.
44. O'Carroll R. E., Hayes P. C., Ebmeier K. P., Dougall N., Murray C., Best J. J. K., Bouchier I. A. D., and Goodwin G. M. (1991) Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancer 337, 1250-1253.
45. Ortega-Corona B. G., Valencia-Sanchez A., Kubli-Garfias C., Anton-Tay F., Salazar L. A., Villareal J. E., and Ponce-Monter H. (1994) Hypothalamic monoamine oxidase activity in ovariectomized rats after sexual behavior restoration. Arch. Med. Res. 25, 337-340.
46. Papadopoulos V., Guarneri P., Krueger K. E., Guidotti A., and Costa E. (1992) Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor. Proc. Natl. Acad. Sci. USA 89, 5113-5117.
47. Rao M. L. and Moller H. J. (1994) Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment. A review. Neuropsychopharmacology 30, 160-172.
48. 3H] ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci. Lett. 182, 69-72.
49. B in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res. 621, 349-352.
50. 3H]PK11195 in rats following portacaval anastomosis. Dig. Dis. Sci. 39, 1055-1063.
51. Rodriguez G., Testa R., Celle G., Gris A., Marenco S., Nobili F., Novellone G., and Rosadini G. (1987) Reduction of cerebral blood flow in subclinical hepatic encephalopathy and its correlation with plasma-free tryptophan. J. Cereb. Blood Flow Metab. 7, 768-772.
52. Saura J., Luque J. M., Cesura A. M., Da Prada M., Chan-Palay V., Huber G., Löffler J., and Richards J. G. (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62, 15-30.
53. Shih J. C. (1991) Molecular basis of human MAO A and B. Neuropsychopharmacology 4, 1-7.
54. Sims K. B., Ozelius L., Corey T., Rinehart W. B., Liberfarb R., Haines J., Chen W. J., Norio R., Sankila E., De La Chapelle A., Murphy D., Gusella J., and Breakefield X. O. (1989) The Norrie disease gene is distinct from the monoamine oxidase genes. Am. J. Hum. Genet. 45, 424-434.
55. Tabakoff B., Hoffman P. L., Lee J. M., Saito T., Willard B., and De Leon-Jones F. (1988) Differences in platelet enzyme activity between alcoholics and non-alcoholics. N. Engl. J. Med. 318, 134-139.
56. Thase M. E., Trivedi M. H., and Rush A. J. (1995) MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 12, 185-219.
57. Vanyukov M. M., Moss H. B., Yu L. M., Tarter R. E., and Deka R. (1995) Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. Am. J. Med. Genet. 60, 122-126.
58. Vorobioff J., Garcia-Tsao G., Groszmann R., Aceves G., Picabea E., Villacencio R., and Hernandez-Ortiz J. (1988) Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients. Hepatology 9, 88-91.
59. Westlund K. N., Denney R. M., Rose R. M., and Abell C. W. (1988) Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25, 439-456.
60. Weyler W., Hsu Y.-P. P., and Breakefield X. O. (1990) Biochemistry and genetics of monoamine oxidase. Pharmacol. Ther. 47, 391-417.
61. Young S. N. and Lal S. (1980) CNS tryptamine metabolism in hepatic coma. J. Neural Transm. 47, 153-161.